| # | Drug | Count |
|---|---|---|
| 0 | LUTETIUM LU 177 DOTATATE | 9 |
| 1 | PREDNISONE | 9 |
| 2 | DENOSUMAB | 8 |
| 3 | RANITIDINE | 6 |
| 4 | DOXAZOSIN | 5 |
| 5 | DOXAZOSIN MESYLATE | 5 |
| 6 | FINGOLIMOD HCL | 5 |
| 7 | METOCLOPRAMIDE HYDROCHLORIDE | 5 |
| 8 | METOPROLOL TARTRATE | 5 |
| 9 | PROPRANOLOL HYDROCHLORIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOXYBENZAMINE HYDROCHLORIDE | 1 | 0.0370 |
| 1 | METYROSINE | 2 | 0.0247 |
| 2 | PHENDIMETRAZINE TARTRATE | 1 | 0.0172 |
| 3 | PHENTOLAMINE MESYLATE | 1 | 0.0062 |
| 4 | LUTETIUM LU 177 DOTATATE | 9 | 0.0015 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 4 | 0.0008 |
| 6 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 7 | NALDEMEDINE | 1 | 0.0006 |
| 8 | MARAVIROC | 1 | 0.0004 |
| 9 | ELOTUZUMAB | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 2 | 0.0247 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 4 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 4 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |